Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-901P (RNA, U6 small nuclear 901, pseudogene) is a non-coding RNA gene classified as a pseudogene derivative of the U6 small nuclear RNA gene family, annotated in Ensembl as ENSG00000207323 on chromosome 3[5][1][3]. As a pseudogene, it does not produce a functional U6 snRNA and has no protein product or reported biological function. Although there is growing evidence that some pseudogenes transcribe regulatory RNAs influencing gene expression, there is no specific evidence that RNU6-901P participates in such roles[2][4]. It is not considered a therapeutic target, nor is it known to interact with drugs, act as a biomarker, or play a role in disease[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 901, pseudogene (RNU6-901P).